Publikationen von T. F. Outeiro
Alle Typen
Zeitschriftenartikel (132)
21.
Zeitschriftenartikel
32 (10), S. 3372 - 3401 (2024)
A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease. Molecular Therapy 22.
Zeitschriftenartikel
20 (10), S. 6776 - 6792 (2024)
Cellular prion protein acts as mediator of amyloid beta uptake by caveolin‐1 causing cellular dysfunctions in vitro and in vivo. Alzheimer's & Dementia 23.
Zeitschriftenartikel
364, 143039 (2024)
A versatile yeast model identifies the pesticides cymoxanil and metalaxyl as risk factors for synucleinopathies. Chemosphere 24.
Zeitschriftenartikel
168 (8), S. 1608 - 1624 (2024)
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry 25.
Zeitschriftenartikel
168 (8), S. 1514 - 1526 (2024)
Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry 26.
Zeitschriftenartikel
168 (8), S. 1625 - 1639 (2024)
PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry 27.
Zeitschriftenartikel
14 (5), S. 917 - 924 (2024)
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms. Journal of Parkinson's Disease 28.
Zeitschriftenartikel
23 (7), S. 669 (2024)
Abandon the NAC in α-synuclein. Lancet Neurology 29.
Zeitschriftenartikel
18, 1412450 (2024)
Age-related alterations in efferent medial olivocochlear-outer hair cell and primary auditory ribbon synapses in CBA/J mice. Frontiers in Cellular Neuroscience 30.
Zeitschriftenartikel
14 (4), S. 681 - 692 (2024)
Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue. Journal of Parkinson's Disease: JPD 31.
Zeitschriftenartikel
39 (6), S. 1080 - 1081 (2024)
Reply to: “Rethinking Parkinson's Disease: A Syndromic Perspective”. Movement Disorders 32.
Zeitschriftenartikel
39 (6), S. 929 - 933 (2024)
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders 33.
Zeitschriftenartikel
49, S. 1643 - 1654 (2024)
Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson’s Disease. Neurochemical Research 34.
Zeitschriftenartikel
122, 106078 (2024)
Towards a biological diagnosis of PD. Parkinsonism & Related Disorders 35.
Zeitschriftenartikel
23 (5), e14128 (2024)
Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell 36.
Zeitschriftenartikel
39 (4), S. 321 - 328 (2024)
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene. Neurología (English Edition) 37.
Zeitschriftenartikel
15 (4), 264 (2024)
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death and Disease 38.
Zeitschriftenartikel
31, S. 3797 - 3804 (2024)
Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose. Cellulose 39.
Zeitschriftenartikel
22, S. 2670 - 2676 (2024)
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry 40.
Zeitschriftenartikel
125 (3), e30523 (2024)
In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry